| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $292.6M | +37.0% |
| Cost of Revenue | $84.8M | -44.7% |
| R&D Expense | $129.1M | -12.7% |
| SG&A Expense | $138.7M | -20.4% |
| Operating Income | -$79.1M | +70.2% |
| Pre-tax Income | -$92.6M | +67.3% |
| Income Tax | $0 | — |
| Net Income | -$92.6M | +67.3% |
| EPS (Basic) | -$0.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.5M | -39.6% |
| Accounts Receivable | $39.2M | -23.0% |
| Inventory | $21.8M | -43.0% |
| Current Assets | $184.9M | -32.0% |
| Total Assets | $351.8M | -33.1% |
| Current Liabilities | $124.8M | -51.4% |
| Long-term Debt | $66.1M | -32.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.2M | +71.1% |
| Capital Expenditures | $114K | +93.2% |
| Investing Cash Flow | -$114K | -100.3% |
| Financing Cash Flow | $14.6M | -89.1% |
| Free Cash Flow | -$73.3M | +71.0% |
| +70.0% |
| EPS (Diluted) | -$0.51 | +70.0% |
| Total Liabilities |
| $342.5M |
| -23.7% |
| Stockholders' Equity | $9.3M | -87.8% |